newsfilter
← Latest News
GlobeNewswire·

Adhera Therapeutics Appoints Trond K. Waerness to Board of Directors

Baton Rouge, LA, April 23, 2021 (GLOBE NEWSWIRE) -- Adhera Therapeutics, Inc. (OTCPK: ATRX) ("Adhera Therapeutics" or the "Company"), a clinical stage biopharmaceutical company engaged in the development of novel cancer products and a proprietary vacci